|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45,600.00 VND | -0.65% |
|
-1.19% | -13.14% |
| 05-26 | Imexpharm Corporation Announces Board Resignations | CI |
| 04-23 | Imexpharm Corporation Approves Cash Dividend for the Year 2025; Provides Dividend Guidance for the Fiscal Year 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.65% | -1.19% | -3.08% | -18.72% | -13.14% | -11.63% | +76.15% | +29.72% | +279.05% | 269M | |
| -1.63% | -6.10% | +10.33% | +18.74% | +1.44% | +38.86% | +141.21% | +398.80% | +1,387.62% | 992B | |
| -2.75% | -4.37% | -0.44% | -3.95% | +10.13% | +51.20% | +38.86% | +40.70% | +95.56% | 564B | |
| -2.26% | -3.97% | +3.08% | +3.60% | -5.53% | +16.37% | +56.62% | +90.82% | +259.09% | 391B | |
| -2.90% | +0.68% | +1.02% | +0.68% | -0.64% | +24.66% | +16.53% | -6.40% | +35.65% | 330B | |
| -2.36% | -3.12% | -4.06% | -7.86% | -4.61% | +24.71% | +12.95% | +56.89% | +241.84% | 280B | |
| -2.45% | -2.88% | +0.72% | -1.22% | +7.70% | +24.29% | +29.93% | +37.70% | +55.42% | 279B | |
| -1.91% | -0.87% | -2.06% | +15.98% | -13.88% | -41.95% | -48.26% | +8.88% | +64.28% | 196B | |
| -1.71% | -5.26% | +3.40% | -4.57% | +2.48% | +15.81% | +46.74% | +40.53% | +122.65% | 184B | |
| -2.36% | -2.44% | -5.30% | -13.09% | +0.05% | +13.70% | +58.02% | +84.36% | +47.97% | 156B | |
| -3.18% | -4.32% | -1.14% | -8.35% | +0.56% | +4.86% | -36.35% | -35.48% | -27.42% | 148B | |
| -1.39% | +1.43% | +3.40% | -0.04% | -0.43% | +0.67% | +31.73% | +140.31% | +420.55% | 116B | |
| -2.87% | -5.79% | -6.46% | -9.71% | -0.62% | +14.44% | -18.82% | -19.35% | -24.46% | 113B | |
| -2.06% | -3.88% | -1.35% | -3.65% | -11.34% | -11.44% | -22.38% | -16.64% | +5.53% | 104B | |
| -2.51% | -2.01% | +2.48% | -2.51% | +5.40% | +32.67% | +42.25% | +8.08% | +8.57% | 105B | |
| -1.10% | +0.08% | -4.69% | -18.80% | -8.21% | +2.46% | +78.32% | +74.09% | +536.69% | 78.57B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +2.00% | -0.65% | -4.55% | -13.45% | +4.18% | +15.93% | +10.17% | +34.07% | +16.68% | 48.69B | |
| +3.04% | +3.00% | -10.32% | -14.00% | -18.72% | -6.60% | +1.94% | -31.95% | +231.79% | 45.99B | |
| -1.56% | +3.80% | -1.80% | -6.02% | +0.38% | +36.56% | -28.03% | -29.57% | -58.91% | 42.98B | |
| Average | -1.58% | +0.83% | -1.10% | -4.57% | -2.36% | +12.93% | +25.66% | +47.66% | +194.64% | 211.91B | |
| Weighted average by Cap. | -2.13% | -0.10% | +2.03% | +2.32% | +0.34% | +23.80% | +51.16% | +122.98% | +422.47% |
- Stock Market
- Stocks
- IMP Stock
- Sector Imexpharm Corporation
Select your edition
All financial news and data tailored to specific country editions
